Cargando…

Estimating the potential impact and diagnostic requirements for SARS-CoV-2 test-and-treat programs

Mostrar otras versiones (1)

Oral antivirals have the potential to reduce the public health burden of COVID-19. However, now that we have exited the emergency phase of the COVID-19 pandemic, declining SARS-CoV-2 clinical testing rates (average testing rates = ≪10 tests/100,000 people/day in low- and-middle income countries; <...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Alvin X., Hannay, Emma, Carmona, Sergio, Rodriguez, Bill, Nichols, Brooke E., Russell, Colin A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558441/ https://www.ncbi.nlm.nih.gov/pubmed/36238715 http://dx.doi.org/10.1101/2022.10.05.22280727

Ejemplares similares

Estimating the potential impact and diagnostic requirements for SARS-CoV-2 test-and-treat programs
por: Han, Alvin X., et al.
Publicado: (2023)

SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs
por: Han, Alvin X., et al.
Publicado: (2022)

SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs
por: Han, Alvin X., et al.
Publicado: (2023)

Strategies for Using Antigen Rapid Diagnostic Tests to Reduce Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Low- and Middle-Income Countries: A Mathematical Modelling Study Applied to Zambia
por: Han, Alvin X, et al.
Publicado: (2022)

SARS-CoV-2 testing for public health use: core principles and considerations for defined use settings
por: Boehme, Catharina, et al.
Publicado: (2021)

Optimal use of COVID-19 Ag-RDT screening at border crossings to prevent community transmission: A modeling analysis
por: Chevalier, Joshua M., et al.
Publicado: (2022)

Breaking the cycle of neglect: building on momentum from COVID-19 to drive access to diagnostic testing
por: Hannay, Emma, et al.
Publicado: (2023)

COVID-19 diagnostics: preserving manufacturing capacity for future pandemics
por: Hannay, Emma, et al.
Publicado: (2022)

SARS-CoV-2 Supply Shortages and Tuberculosis Diagnostics: Current Issues Requiring Immediate Solutions
por: Armstrong, Derek T., et al.
Publicado: (2021)

Phylogenetic Clustering by Linear Integer Programming (PhyCLIP)
por: Han, Alvin X, et al.
Publicado: (2019)

The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada
por: Brown, Kevin A., et al.
Publicado: (2021)

SARS-CoV-2 infection: diagnostic testing results occasionally require special attention
por: Riva, Elisabetta, et al.
Publicado: (2020)

Bringing Data Analytics to the Design of Optimized Diagnostic Networks in Low- and Middle-Income Countries: Process, Terms and Definitions
por: Nichols, Kameko, et al.
Publicado: (2020)

Regional importation and asymmetric within-country spread of SARS-CoV-2 variants of concern in the Netherlands
por: Han, Alvin X, et al.
Publicado: (2022)

A modelling framework for translating discrete choice experiment results into cost‐effectiveness estimates: an application to designing tailored and scalable HIV and contraceptive services for adolescents in Gauteng, South Africa
por: Govathson, Caroline, et al.
Publicado: (2023)

Evaluation of SARS-CoV-2 rapid antigen diagnostic tests for saliva samples
por: Hagbom, Marie, et al.
Publicado: (2022)

COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic
por: Lee, Alvin J. X., et al.
Publicado: (2021)

Regional importation and asymmetric within-country spread of SARS-CoV-2 variants of concern in the Netherlands
por: Han, Alvin X., et al.
Publicado: (2022)

Analysis of SARS-CoV-2 in wastewater for prevalence estimation and investigating clinical diagnostic test biases
por: Mattei, Mattia, et al.
Publicado: (2023)

Estimating the strength of selection for new SARS-CoV-2 variants
por: van Dorp, Christiaan H., et al.
Publicado: (2021)

Estimating the strength of selection for new SARS-CoV-2 variants
por: Dorp, Christiaan H. van, et al.
Publicado: (2021)

Posterior Reversible Encephalopathy Syndrome in a Patient With SARS-CoV-2 Infection Treated With Tocilizumab
por: Talluri, Krishna, et al.
Publicado: (2021)

An Overview of SARS-CoV-2 Molecular Diagnostics in Europe
por: Davies, Emma, et al.
Publicado: (2022)

Global estimates of the fitness advantage of SARS-CoV-2 variant Omicron
por: van Dorp, Christiaan, et al.
Publicado: (2022)

Global estimates of the fitness advantage of SARS-CoV-2 variant Omicron
por: van Dorp, Christiaan, et al.
Publicado: (2022)

SARS-CoV-2 associated acute, motor and sensory, axonal neuropathy requires comprehensive diagnostic work-up
por: Finsterer, Josef, et al.
Publicado: (2023)

SARS-CoV-2 testing strategies for outbreak mitigation in vaccinated populations
por: Kumar, Chirag K., et al.
Publicado: (2022)

SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge
por: Ezhilan, Madeshwari, et al.
Publicado: (2021)

Health Outcomes and Cost-effectiveness of Monoclonal SARS-CoV-2 Antibodies as Pre-exposure Prophylaxis
por: Popping, Stephanie, et al.
Publicado: (2023)

Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis
por: Brümmer, Lukas E., et al.
Publicado: (2021)

SARS-CoV-2 infection in children requiring hospitalization: the experience of Navarra, Spain
por: Moreno-Galarraga, Laura, et al.
Publicado: (2020)

Estimating seroprevalence of SARS-CoV-2 in Ohio: A Bayesian multilevel poststratification approach with multiple diagnostic tests
por: Kline, David, et al.
Publicado: (2021)

De novo altered mental state after SARS-CoV-2 vaccination requires extensive diagnostic work-up
por: Finsterer, Josef
Publicado: (2022)

Efficiency of Diagnostic Test for SARS-CoV-2 in a Nursing Home
por: Salmerón, Sergio, et al.
Publicado: (2022)

Estimating the burden of SARS-CoV-2 in France
por: Salje, Henrik, et al.
Publicado: (2020)

Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells
por: Daniloski, Zharko, et al.
Publicado: (2021)

C(t) values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load
por: Dahdouh, Elias, et al.
Publicado: (2021)

Diagnostic Salivary Tests for SARS-CoV-2
por: Azzi, L., et al.
Publicado: (2020)

The Interpretation of SARS-CoV-2 Diagnostic Tests
por: Stites, Edward C., et al.
Publicado: (2020)

Pitfalls in SARS‐CoV‐2 PCR diagnostics
por: Wernike, Kerstin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pcun6uush29qoka07e5ijmcfle